Harangi M - Search Results

1

Determining the prevalence of childhood hypertension and its concomitant metabolic abnormalities using data mining methods in the Northeastern region of Hungary.

Kovács B, Németh Á, Daróczy B, Karányi Z, Maroda L, Diószegi Á, Nádró B, Szabó T, Harangi M, Páll D. Kovács B, et al. Among authors: harangi m. Front Cardiovasc Med. 2023 Jan 10;9:1081986. doi: 10.3389/fcvm.2022.1081986. eCollection 2022. Front Cardiovasc Med. 2023. PMID: 36704476 Free PMC article.

2

[The role of HDL in the prevention of cardiovascular events].

Paragh G, Harangi M. Paragh G, et al. Among authors: harangi m. Orv Hetil. 2001 Jan 21;142(3):121-6. Orv Hetil. 2001. PMID: 11217160 Review. Hungarian.

3

High-speed detection of the two common paraoxonase polymorphisms Leu55-->Met and Gln192-->Arg by real-time fluorescence PCR and melting curves.

Harangi M, Aslanidis C, Paragh G, Schmitz G. Harangi M, et al. Clin Chem Lab Med. 2002 Apr;40(4):337-40. doi: 10.1515/CCLM.2002.053. Clin Chem Lab Med. 2002. PMID: 12059071

4

Familial hypercholesterolaemia in children and adolescents from 48 countries: a cross-sectional study.

European Atherosclerosis Society Familial Hypercholesterolaemia Studies Collaboration. European Atherosclerosis Society Familial Hypercholesterolaemia Studies Collaboration. Lancet. 2024 Jan 6;403(10421):55-66. doi: 10.1016/S0140-6736(23)01842-1. Epub 2023 Dec 12. Lancet. 2024. PMID: 38101429 Free article.

5

Cerebrotendinous xanthomatosis with the c.379C>T (p.R127W) mutation in the CYP27A1 gene associated with premature age-associated limbic tauopathy.

Kapás I, Katkó M, Harangi M, Paragh G, Balogh I, Kóczi Z, Regelsberger G, Molnár MJ, Kovacs GG. Kapás I, et al. Among authors: harangi m. Neuropathol Appl Neurobiol. 2014 Apr;40(3):345-50. doi: 10.1111/nan.12058. Neuropathol Appl Neurobiol. 2014. PMID: 23659550 No abstract available.

6

The molecular and clinical rationale of extracorporeal photochemotherapy in autoimmune diseases, malignancies and transplantation.

Szodoray P, Papp G, Nakken B, Harangi M, Zeher M. Szodoray P, et al. Among authors: harangi m. Autoimmun Rev. 2010 Apr;9(6):459-64. doi: 10.1016/j.autrev.2009.12.011. Epub 2010 Jan 1. Autoimmun Rev. 2010. PMID: 20044039 Review.

7

[Statin-induced adverse effects -- facts and genes].

Harangi M, Zsíros N, Juhász L, Paragh G. Harangi M, et al. Orv Hetil. 2013 Jan 20;154(3):83-92. doi: 10.1556/OH.2013.29530. Orv Hetil. 2013. PMID: 23315223 Review. Hungarian.

8

The c.-133A > G polymorphism in NPC1L1 gene influences the efficacy of ezetimibe monotherapy on apolipoprotein A1 in hyperlipidemic patients.

Zsíros N, Bodor M, Varga V, Berta E, Balogh I, Seres I, Paragh G, Harangi M. Zsíros N, et al. Among authors: harangi m. Pharmazie. 2014 Jun;69(6):424-9. Pharmazie. 2014. PMID: 24974575

9

[Clinical significance of and treatment options for increased lipoprotein(a)].

Zsíros N, Paragh G, Harangi M. Zsíros N, et al. Among authors: harangi m. Orv Hetil. 2014 Apr 20;155(16):607-14. doi: 10.1556/OH.2014.29877. Orv Hetil. 2014. PMID: 24733102 Review. Hungarian.

10

Effect of thyroid hormone status and concomitant medication on statin induced adverse effects in hyperlipidemic patients.

Berta E, Harangi M, Zsíros N, Nagy EV, Paragh G, Bodor M. Berta E, et al. Among authors: harangi m. Pharmazie. 2014 Jun;69(6):420-3. Pharmazie. 2014. PMID: 24974574

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

107 results

Search Page

Filters